fbpx

molecules of the month

“compound 34”

oral PARP1-selective polymerase inhibitor

oral efficacy in BRCA1 mutant xenograft

from scaffold hopping from lit. PARP1/2 inh.

Bioorg. Med. Chem., Oct. 6, 2020

Lupin Ltd., Pune, IN

Structure of compound 34
1 min read

“compound 34” (Lupid oral in vivo PARP1-selective polymerase inhibitor)


request a trial

Drug Hunter is commited to helping industry innovators make informed decisions. Premium members have access to our library of the latest stories in science, written by scientists.

Request a trial to access insights powering the pros in our industry.


already a member? log in: